Denali Therapeutics Inc.
FUSION PROTEINS COMPRISING PROGRANULIN

Last updated:

Abstract:

Provided herein are fusion proteins that comprise progranulin and an Fc polypeptide. Methods of using such proteins to treat progranulin-associated disorders (e.g., a neurodegenerative disease, such as frontotemporal dementia (FTD)) are also provided herein.

Status:
Application
Type:

Utility

Filling date:

18 Jun 2019

Issue date:

16 Sep 2021